Aspects of release of pharmacologically active substances from the lungs by chemical stimuli

scientific article published on July 1, 1976

Aspects of release of pharmacologically active substances from the lungs by chemical stimuli is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1007/BF01973279
P8608Fatcat IDrelease_xckj5efic5do7bpa6hbjgjvis4
P953full work available at URLhttp://link.springer.com/article/10.1007/BF01973279/fulltext.html
http://link.springer.com/content/pdf/10.1007/BF01973279
http://link.springer.com/content/pdf/10.1007/BF01973279.pdf
P698PubMed publication ID183490

P2093author name stringB. B. Vargaftig
P2860cites workBiochimica et Biophysica ActaQ864239
Aspirin selectively inhibits prostaglandin production in human plateletsQ71062251
Circulatory and respiratory effects of induced platelet aggregation. An experimental study in dogsQ71081735
Preliminary report on tyramine headacheQ71205120
Liberation of histamine from the perfused lung by snake venomsQ80329520
Migraine: a pulmonary disease?Q93717509
Removal of 5-hydroxytryptamine in the pulmonary circulation of rat isolated lungsQ95784177
Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugsQ29617192
Liberation of histamine and formation of lysocithin-like substances by cobra venomQ34568156
Proceedings: Role of platelet aggregation in bronchoconstriction in guinea-pigsQ35175617
A phenylethylamine oxidising defect in migraineQ38588026
Histamine release, formation of prostaglandin-like activity (SRS-C) and mast cell degranulation by the direct lytic factor (DLF) and phospholipase A of cobra venomQ39334733
Granulocyte collagenase, elastase and plasma protease inhibitors in purulent sputumQ39336983
Collagenase and rheumatoid arthritisQ39892286
The lung in relation to vasoactive hormonesQ39898935
Pharmacokinetic function of the pulmonary circulationQ39902598
Handling of bioactive materials by the lung (first of two parts).Q39945989
Release of spasmogenic substances induced by vasoactive amines from isolated lungsQ40003418
Haemorrhagic and inflammatory properties of collagenase fromC. histolyticumQ40017987
The release of biologically active substances from isolated lungs by 5-hydroxytryptamine and tryptamineQ41336392
Analgesic antipyretic drugs as antagonists of bradykininQ42145278
Inhibition by non-steroid anti-inflammatory agents of rabbit aorta contracting activity generated in blood by slow reacting substance C.Q43001217
Proceedings: The nature of the tryptamine receptor mediating spasmogen release from rat isolated lungsQ43001399
Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugsQ46576516
Interference of some thiol derivatives with the pharmacological effects of arachidonic acid and slow reacting substance C and with the release of rabbit aorta contracting substancesQ46627184
Prostaglandin endoperoxides IV. Effects on smooth muscleQ46696570
Release of vasoactive substances from guinea-pig lungs by slow-reacting substance c and arachidonic acid. Its blockade by nonsteroid anti-inflammatory agentsQ46699453
SUSCEPTIBILITY OF ERYTHROCYTES OF VARIOUS ANIMAL SPECIES TO THE HEMOLYTIC AND PHOSPHOLIPID SPLITTING ACTION OF SNAKE VENOM.Q46961823
Release of histamine and formation of smooth-muscle stimulating principles in guinea-pig lung tissue induced by antigen and bee venom phosphatidase A.Q52470242
Comparison of hemorrhagic factors of the venoms of Naja naja, Agkistrodon piscivorus and Apis melliferaQ52494217
[Biochemical and immunological research on snake venom. II. Study of the enzymatic and toxic properties of the fractions obtained by filtration of the venom of Naja nigricollis on sephadex].Q53980922
Inhibition by non-steroidal anti-inflammatory agents of in vivo effects of "slow reacting substance C".Q54070200
Isolation of a chemical trigger for thrombosisQ54258796
Platelet Aggregation induced by Arachidonic Acid is accompanied by Release of Potential Inflammatory Mediators distinct from PGE2 and PGF2Q54417600
Paradoxical inhibition of the effects of bradykinin by some sulfhydryl reagentsQ67298594
[Arachidonic acid release by bradykinin]Q68547921
[Formation by phospholipase A of SRS-C in perfused guinea pig lung. Identification with prostaglandin]Q68732618
Selective inhibition by mepacrine of the release of "rabbit aorta contracting substance" evoked by the administration of bradykininQ68764240
Pharmacological evidence for a vasodilator receptor to serotonin in the nasal vessels of the dogQ68841319
Effects of arachidonic acid on systemic arterial pressure, myocardial contractility and platelets in the dogQ68863000
Inhibition by sulfhydryl agents of arachidonic acid-induced platelet aggregation and release of potential inflammatory substancesQ68882537
Release of histamine from rat mast cells: a comparison of the effects of 48-80 and two antigen systemsQ70118607
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectimmunologyQ101929
pharmacologyQ128406
P304page(s)551-557
P577publication date1976-07-01
P1433published inAgents and ActionsQ23928727
P1476titleAspects of release of pharmacologically active substances from the lungs by chemical stimuli
P478volume6